Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:ASTTSE:WTE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsWTEWestshore Terminals InvestmentC$25.32-0.4%C$24.43C$21.60▼C$26.78C$1.56B0.86124,085 shs163,260 shs20 Stocks to Sell NowGet This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%WTEWestshore Terminals Investment+2.13%+2.33%-2.15%+7.07%+0.12%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AWTEWestshore Terminals Investment0.8881 of 5 stars1.00.01.70.01.91.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTAsterias Biotherapeutics 0.00N/AN/AN/AWTEWestshore Terminals Investment 2.00HoldC$26.133.18% UpsideCurrent Analyst Ratings BreakdownLatest WTE, AST, WCAT, and SCIR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/26/2025WTEWestshore Terminals InvestmentRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetSector PerformC$25.00(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AWTEWestshore Terminals InvestmentC$382.55M4.09C$2.91 per share8.71C$11.44 per share2.21Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTAsterias BiotherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/AWTEWestshore Terminals InvestmentC$106.15MC$1.7214.73∞N/A27.75%14.93%6.45%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AWTEWestshore Terminals InvestmentC$1.505.92%N/A87.28%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTAsterias BiotherapeuticsN/AN/AN/AWTEWestshore Terminals Investment62.461.082.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTAsterias BiotherapeuticsN/AWTEWestshore Terminals Investment17.75%Insider OwnershipCompanyInsider OwnershipASTAsterias BiotherapeuticsN/AWTEWestshore Terminals Investment47.62%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTAsterias BiotherapeuticsN/A55.66 millionN/ANot OptionableWTEWestshore Terminals Investment42361.77 millionN/ANot OptionableWTE, AST, WCAT, and SCIR HeadlinesRecent News About These CompaniesRBC Capital Sticks to Their Hold Rating for Westshore Terminals (WTE)April 24 at 6:19 AM | markets.businessinsider.comWestshore Terminals Investment (TSE:WTE) Stock Crosses Above 200 Day Moving Average - Should You Sell?April 20, 2025 | marketbeat.comWestshore Terminals Investment (TSE:WTE) Share Price Crosses Above 200-Day Moving Average - Should You Sell?April 13, 2025 | marketbeat.comBullish Westshore Terminals Investment Insiders Loaded Up On CA$1.79m Of StockApril 10, 2025 | finance.yahoo.comWestshore Terminals Investment (TSE:WTE) Stock Price Passes Above 200 Day Moving Average - Here's What HappenedApril 4, 2025 | marketbeat.comInvesting in Canada: Opportunities in Nutrien and Westshore TerminalsMarch 28, 2025 | msn.comInvesting in Canada: Opportunities in Nutrien and Westshore TerminalsMarch 28, 2025 | msn.comRoyal Bank of Canada Reiterates "C$25.00" Price Target for Westshore Terminals Investment (TSE:WTE)March 27, 2025 | marketbeat.comWESTSHORE TERMINALS FILES 2024 DISCLOSURE DOCUMENTSMarch 15, 2025 | finance.yahoo.comWESTSHORE TERMINALS ANNOUNCES Q1 2025 DISTRIBUTION AND PROVIDES UPDATE ON POTASH PROJECTMarch 15, 2025 | finance.yahoo.comWESTSHORE TERMINALS ANNOUNCES Q1 2025 DISTRIBUTION AND PROVIDES UPDATE ON POTASH PROJECTMarch 15, 2025 | finance.yahoo.comThe five-year decline in earnings for Westshore Terminals Investment TSE:WTE) isn't encouraging, but shareholders are still up 67% over that periodDecember 17, 2024 | finance.yahoo.comWestshore Terminals Investment Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen NextNovember 8, 2024 | finance.yahoo.comWestshore Terminals Investment: Still Not Attractive, But I Am Upgrading To HoldNovember 7, 2024 | seekingalpha.comWestshore Terminals: Top 25 Undervalued Dividend Stocks on TSX (WTE)October 17, 2024 | theglobeandmail.comCalculating The Intrinsic Value Of Westshore Terminals Investment Corporation (TSE:WTE)October 10, 2024 | finance.yahoo.comWestshore Terminals Investment CorpSeptember 12, 2024 | morningstar.comIs Now The Time To Look At Buying Westshore Terminals Investment Corporation (TSE:WTE)?August 27, 2024 | finance.yahoo.comWestshore Terminals Investment Second Quarter 2024 Earnings: Beats ExpectationsAugust 8, 2024 | finance.yahoo.comWestshore Terminals Investment Corporation (TSE:WTE) boasts of bullish insider sentiment with 48% ownership and they have been buying latelyAugust 1, 2024 | finance.yahoo.comInsider Stock Buying Reaches CA$60.5m On Westshore Terminals InvestmentMay 21, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines5 Highest-Rated Dividend Stocks According to MarketBeatBy Thomas Hughes | April 10, 2025View 5 Highest-Rated Dividend Stocks According to MarketBeatBuffett’s Next Oil Bet: Why Occidental Is DifferentBy Jea Yu | April 8, 2025View Buffett’s Next Oil Bet: Why Occidental Is DifferentWhy NVIDIA Stock Could Soar Despite Wall Street DowngradesBy Thomas Hughes | April 14, 2025View Why NVIDIA Stock Could Soar Despite Wall Street DowngradesAST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer StockBy Jea Yu | April 21, 2025View AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer StockThese 3 Stocks Have Huge Last 12 Months Shareholder YieldsBy Leo Miller | April 18, 2025View These 3 Stocks Have Huge Last 12 Months Shareholder YieldsWTE, AST, WCAT, and SCIR Company DescriptionsAsterias Biotherapeutics NYSEAMERICAN:AST$0.0020 0.00 (0.00%) As of 07/10/2019Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.Westshore Terminals Investment TSE:WTEC$25.32 -0.11 (-0.43%) As of 04:00 PM EasternWestshore Terminals Investment Corporation is a Canada-based company, which owns the Westshore Terminals Limited Partnership. The company operates a coal storage and loading terminal at Roberts Bank, British Columbia, and revenue is derived from rates charged for loading coal onto seagoing vessels. The company services coal from mines in British Columbia, Alberta, and the northwestern United States. The coal is delivered to the terminal in unit trains and then unloaded and transferred onto a ship. It is then shipped to multiple countries across the world, with the majority headed to Japan, Korea and China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Market Anticipation Builds: Joby Stock Climbs Ahead of Earnings Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? Now Is the Time to Buy ServiceNow—The Rebound Is Real Archer Aviation Gets Analyst Target Upgrade: Time to Load Up? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
